About
Company Strategy
Group Structure
Board of directors
Management
Career
Contacts
Development
Drugs
Medical devices
Medical services
Biotech valuation
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Investor
Disclosure of information
News
En
RU
CN
Главная
News
News
News, press releases, events, publications
Press releases
All categories
Portfolio
Portfolio
Genetico
Gemabank
Nextgen
Biotechnology Developments
Betuvax
Histograft
Genotarget
28.12.2024
Press releases
Cifra Broker has published an analytical review of Artgen Biotech for 9 months of 2024
20.12.2024
Press releases
Vaccine against cat allergies attracts venture capital investments
17.12.2024
Press releases
Nextgen Company has become a member of the Chamber of Commerce and Industry of the Russian Federation
13.12.2024
Press releases
Artgen Biotech is in the GR rating of the largest Russian companies without government participation
11.12.2024
Press releases
Tauren Investments has published an analytical report on Gemabank
09.12.2024
Press releases
Gemabank will pay dividends for 9 months of 2024
05.12.2024
Press releases
The first patients received injections of a new drug for interstitial cystitis
1
…
7
8
9
10
11
…
20
Up
About the Company
About
Company Strategy
Group Structure
Board of Directors
Management
Career
Contacts
Development Portfolio
Drugs
Medical Devices
Medical Services
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Biotech Valuation
Investors
Disclosure of information
